Related Experiment Videos
Treatment of angina pectoris by percutaneous transluminal coronary angioplasty
Insights
Percutaneous transluminal coronary angioplasty (PTCA) effectively treated angina pectoris by significantly reducing coronary artery stenosis and weekly anginal attacks in patients. This minimally invasive procedure proved safe and beneficial for managing chest pain associated with coronary artery disease.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Angina pectoris is a common symptom of coronary artery disease.
- Effective treatment options for angina are crucial for improving patient quality of life.
- Percutaneous transluminal coronary angioplasty (PTCA) is an established interventional procedure.
Purpose of the Study:
- To evaluate the effectiveness and safety of PTCA in patients suffering from angina pectoris.
- To assess the impact of PTCA on coronary artery stenosis and anginal symptom frequency.
Main Methods:
- PTCA was performed on a cohort of 12 patients diagnosed with angina pectoris.
- Stenosis percentage of the affected coronary artery was measured before and after the procedure.
- The frequency of anginal attacks per week was recorded pre- and post-PTCA.
Main Results:
- PTCA significantly reduced coronary artery stenosis from a mean of 75.6% to 32.6%.
- The average number of weekly anginal attacks decreased substantially from 8.4 to 2.5.
- No life-threatening complications were reported during or after the PTCA procedures.
Conclusions:
- PTCA demonstrates significant effectiveness in treating angina pectoris.
- The procedure leads to substantial improvements in both anatomical stenosis and clinical symptoms.
- PTCA is a safe and viable therapeutic option for patients with angina pectoris.
Abstract:
Percutaneous transluminal coronary angioplasty (PTCA) was performed on 12 patients with angina pectoris. PTCA reduced the percentage of stenosis of the coronary artery from 75.6 +/- 10.1 (means +/- SD) to 32.6 +/- 19.5. In addition, anginal attacks per week was reduced from 8.4 +/- 3.2 to 2.5 +/- 0.7. No life-threatening complications were produced by PTCA. The results indicates the effectiveness of PTCA as a treatment for angina pectoris.